The Brain Health Institute (BHI) at Rutgers, The State University of New Jersey, was established in 2014 to become an internationally recognized center for basic, translational, and clinical research into the biological bases of human brain function and dysfunction.
The mission of BHI is to support and coordinate neuroscience across Rutgers University’s dynamic and diverse neuroscience communities toward common goals:
- Create research programs focused on understanding the biological underpinnings of the central nervous system’s function and dysfunction.
- Develop treatments for these disorders using novel neuroscience tools.
- Establish a rich neuroscience resource in New Jersey that provides education to the public, clinicians, faculty, and students, as well as state, national, and international health officials.
The BHI will develop neuroscience at Rutgers to become a highly translational and internationally preeminent research enterprise, to advance new treatments for debilitating nervous system disorders. We are dedicated to integrating cutting-edge basic and clinical research, developing robust educational programs, enhancing scientific collaborations, and providing state-of-the-art infrastructure for brain research.
The BHI includes more than 300 faculty engaged in neuroscience and brain health-related research at Rutgers. The research programs span multiple disciplines with faculty across 33 departments and seven schools of various campuses of Rutgers University and Rutgers Biomedical and Health Sciences (RBHS). The BHI is a virtual institute with administrative offices located in the School of Public Health/RWJMS Research Building, Busch campus, Piscataway, NJ.
In 2014, Dr. Gary Aston-Jones was recruited to Rutgers as the inaugural Director of the BHI and the Murray and Charlotte Strongwater Endowed Chair in Neuroscience and Brain Health. Dr. Aston-Jones reports to both the Chancellor of RBHS and the Chancellor of Rutgers-New Brunswick and is administered by RBHS.